CYP3A4 and hepatocellular carcinoma: Previous studies showed that overexpression of miR-4277 in HCC cells reduced the elimination of sorafenib in HCC cells and enhanced the sensitivity of HCC cells to sorafenib by inhibiting the expression of CYP3A4 (36).